Abstract
Various forms of biological units that act as both reducing and stabilizing agents have lately been exploited in the creation of bioactive nanoparticles (NPs). Fungi emit enzymes, proteins, and metabolic products as reducing agents, which can be exploited to mass-produce NPs. Despite these benefits, mycogenic synthesis confronts difficulties in managing NP size due to polydispersity. Furthermore, one of the key limitations in fungal and yeast-mediated synthesis is a complete and detailed understanding of the molecular components of NP mycofabrication. Several methods have been proposed to explain the creation of NPs by fungus and yeast, but more research into the fungal system is needed. However, there are some gaps and restrictions on the successful creation of these NPs that the scientific community must address. The application of marine fungi and yeast in the green synthesis of inorganic NPs, as well as an understanding of mechanistic factors, is the emphasis of this review. The limitations of microbial-mediated biosynthesis are also discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Fungal Cell Factories for Sustainable Nanomaterials Production and Agricultural Applications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
